Nasdaq:US$15.14 (-0.26) | HKEX:HK$23.76 (-0.70) | AIM:£2.20 (-0.14)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models